[1]
Luna, A. and Shenouda, M. 2024. The Use of Ibrutinib in Extranodal Marginal Zone Lymphoma of the Ocular Adnexa with Multifocal Disease that is Refractory to Rituximab. Translation: The University of Toledo Journal of Medical Sciences. 12, 5 (Jul. 2024). DOI:https://doi.org/10.46570/utjms.vol12-2024-626.